First Home

Fibronostics to Present New LIVERFASt Data at EASL Congress 2026

Fibronostics is pleased to announce that new data on LIVERFASt™, its non-invasive blood-based diagnostic test for liver disease, will be

Why Monitoring Liver ‘Activity’ is Important?

When people think about liver disease, the conversation usually centers around fibrosis – the amount of permanent scarring in the